MEDP
Medpace Holdings, Inc.
Price Chart
Latest Quote
$588.17
Current Price| Previous Close | $582.48 |
| Open | $576.16 |
| Day High | $593.18 |
| Day Low | $568.86 |
| Volume | 323,218 |
Stock Information
| Shares Outstanding | 28.17M |
| Total Debt | $143.97M |
| Cash Equivalents | $285.35M |
| Revenue | $2.36B |
| Net Income | $432.92M |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Market Cap | $16.57B |
| P/E Ratio | 41.04 |
| EPS (TTM) | $14.33 |
| Exchange | NMS |
📊 Custom Metrics & Score
Score: 28/42| Debt to Equity | 0.15 |
| Debt to Earnings | 0.19 |
| Current Ratio | 0.93 |
| Quick Ratio | 0.87 |
| Avg Revenue Growth | 21.15% |
| Profit Margin | 19.17% |
| Return on Equity | 48.98% |
| Avg FCF Growth | 35.86% |
| FCF Yield | 3.45% |
Score Explanation: The perfect score is 42/42 based on debt levels, profitability, growth rates, and cash flow metrics. FCF Yield is weighted most heavily as it shows what return the business currently generates.
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-02-02 | $588.17 | 323,783 |
| 2026-01-30 | $582.48 | 224,500 |
| 2026-01-29 | $593.07 | 192,500 |
| 2026-01-28 | $597.91 | 169,200 |
| 2026-01-27 | $602.25 | 140,600 |
| 2026-01-26 | $602.06 | 205,100 |
| 2026-01-23 | $588.05 | 301,600 |
| 2026-01-22 | $606.27 | 182,800 |
| 2026-01-21 | $620.59 | 251,200 |
| 2026-01-20 | $602.40 | 207,200 |
| 2026-01-16 | $610.90 | 232,700 |
| 2026-01-15 | $618.04 | 207,100 |
| 2026-01-14 | $616.45 | 196,100 |
| 2026-01-13 | $608.43 | 265,000 |
| 2026-01-12 | $599.21 | 274,600 |
| 2026-01-09 | $595.00 | 189,200 |
| 2026-01-08 | $600.02 | 235,700 |
| 2026-01-07 | $613.09 | 234,300 |
| 2026-01-06 | $608.89 | 206,700 |
| 2026-01-05 | $586.83 | 189,200 |
About Medpace Holdings, Inc.
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
📰 Latest News
Medpace (MEDP) Declines More Than Market: Some Information for Investors
Zacks • 2026-01-30T23:15:03Z
Here’s Why Medpace (MEDP) Shares Roared in 2025
Insider Monkey • 2026-01-30T14:06:51Z
1 Volatile Stock with Solid Fundamentals and 2 We Avoid
StockStory • 2026-01-29T04:34:11Z
Medpace (MEDP) Stock Drops Despite Market Gains: Important Facts to Note
Zacks • 2026-01-23T23:15:02Z
Vulcan Value Partners’ Thoughts on Medpace Holdings (MEDP)
Insider Monkey • 2026-01-23T13:34:51Z
2 Cash-Heavy Stocks with Promising Prospects and 1 We Find Risky
StockStory • 2026-01-19T04:38:34Z
Is Medpace Holdings (MEDP) Still Attractive After 81% One-Year Surge In Share Price?
Simply Wall St. • 2026-01-17T18:07:42Z
S&P 500 Financial Titan BlackRock Leads Five Stocks To Watch
Investor's Business Daily • 2026-01-17T16:37:05Z
How Investors Are Reacting To Medpace Holdings (MEDP) Strong Organic Growth And Efficient Capital Use
Simply Wall St. • 2026-01-17T09:11:44Z
Medpace (MEDP): Buy, Sell, or Hold Post Q3 Earnings?
StockStory • 2026-01-16T04:02:23Z
Income Statement (Annual)
Revenue
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Reconciled Cost Of Revenue | $1,452,749,000 | $1,361,337,000 | $1,027,558,000 | $814,222,000 |
| Cost Of Revenue | $1,452,749,000 | $1,361,337,000 | $1,027,558,000 | $814,222,000 |
| Total Revenue | $2,109,054,000 | $1,885,842,000 | $1,459,996,000 | $1,142,377,000 |
| Operating Revenue | $2,109,054,000 | $1,885,842,000 | $1,459,996,000 | $1,142,377,000 |
Expenses
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Total Expenses | $1,662,184,000 | $1,549,017,000 | $1,181,299,000 | $943,762,000 |
| Other Income Expense | $4,056,000 | $-655,000 | $7,068,000 | $3,342,000 |
| Other Non Operating Income Expenses | $4,552,000 | $1,274,000 | $3,209,000 | $563,000 |
| Net Non Operating Interest Income Expense | $24,996,000 | $-488,000 | $-2,905,000 | $-105,000 |
| Total Other Finance Cost | $-24,996,000 | $488,000 | $2,905,000 | $105,000 |
| Operating Expense | $209,435,000 | $187,680,000 | $153,741,000 | $129,540,000 |
Income & Earnings
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Net Income From Continuing Operation Net Minority Interest | $404,386,000 | $282,810,000 | $245,368,000 | $181,848,000 |
| Net Interest Income | $24,996,000 | $-488,000 | $-2,905,000 | $-105,000 |
| Normalized Income | $404,807,600 | $284,434,218 | $242,022,247 | $179,344,121 |
| Net Income From Continuing And Discontinued Operation | $404,386,000 | $282,810,000 | $245,368,000 | $181,848,000 |
| Total Operating Income As Reported | $446,870,000 | $336,825,000 | $278,697,000 | $198,615,000 |
| Net Income Common Stockholders | $404,342,000 | $282,619,000 | $245,211,000 | $181,390,000 |
| Net Income | $404,386,000 | $282,810,000 | $245,368,000 | $181,848,000 |
| Net Income Including Noncontrolling Interests | $404,386,000 | $282,810,000 | $245,368,000 | $181,848,000 |
| Net Income Continuous Operations | $404,386,000 | $282,810,000 | $245,368,000 | $181,848,000 |
| Pretax Income | $475,922,000 | $335,682,000 | $282,860,000 | $201,852,000 |
| Operating Income | $446,870,000 | $336,825,000 | $278,697,000 | $198,615,000 |
| Depreciation Amortization Depletion Income Statement | $29,251,000 | $26,328,000 | $22,341,000 | $21,119,000 |
| Depreciation And Amortization In Income Statement | $29,251,000 | $26,328,000 | $22,341,000 | $21,119,000 |
| Amortization Of Intangibles Income Statement | $1,443,000 | $2,199,000 | $3,352,000 | $5,114,000 |
| Depreciation Income Statement | $27,808,000 | $24,129,000 | $18,989,000 | $16,005,000 |
| Gross Profit | $656,305,000 | $524,505,000 | $432,438,000 | $328,155,000 |
Per Share Metrics
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Diluted EPS | $12.63 | $8.88 | $7.28 | $4.81 |
| Basic EPS | $13.06 | $9.20 | $7.57 | $5.06 |
Other
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Tax Effect Of Unusual Items | $-74,400 | $-304,782 | $513,247 | $275,121 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $476,617,000 | $365,082,000 | $297,179,000 | $216,955,000 |
| Total Unusual Items | $-496,000 | $-1,929,000 | $3,859,000 | $2,779,000 |
| Total Unusual Items Excluding Goodwill | $-496,000 | $-1,929,000 | $3,859,000 | $2,779,000 |
| Reconciled Depreciation | $29,251,000 | $26,328,000 | $22,341,000 | $21,119,000 |
| EBITDA (Bullshit earnings) | $476,121,000 | $363,153,000 | $301,038,000 | $219,734,000 |
| EBIT | $446,870,000 | $336,825,000 | $278,697,000 | $198,615,000 |
| Diluted Average Shares | $32,014,000 | $31,841,000 | $33,671,000 | $37,697,000 |
| Basic Average Shares | $30,957,000 | $30,722,000 | $32,388,000 | $35,862,000 |
| Diluted NI Availto Com Stockholders | $404,342,000 | $282,619,000 | $245,211,000 | $181,390,000 |
| Otherunder Preferred Stock Dividend | $44,000 | $191,000 | $157,000 | $458,000 |
| Tax Provision | $71,536,000 | $52,872,000 | $37,492,000 | $20,004,000 |
| Gain On Sale Of Security | $-496,000 | $-1,929,000 | $3,859,000 | $2,779,000 |
| Amortization | $1,443,000 | $2,199,000 | $3,352,000 | $5,114,000 |
| Selling General And Administration | $180,184,000 | $161,352,000 | $131,400,000 | $108,421,000 |
Balance Sheet (Annual)
Assets
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Net Tangible Assets | $128,783,000 | $-139,255,000 | $-314,017,000 | $249,172,000 |
| Total Assets | $2,100,866,000 | $1,656,828,000 | $1,352,495,000 | $1,659,935,000 |
| Total Non Current Assets | $1,071,637,000 | $1,063,000,000 | $1,018,533,000 | $969,023,000 |
| Other Non Current Assets | $22,254,000 | $24,970,000 | $21,129,000 | $17,422,000 |
| Non Current Deferred Assets | $100,357,000 | $74,435,000 | $48,083,000 | $25,134,000 |
| Non Current Deferred Taxes Assets | $100,357,000 | $74,435,000 | $48,083,000 | $25,134,000 |
| Goodwill And Other Intangible Assets | $696,762,000 | $698,205,000 | $700,404,000 | $703,756,000 |
| Other Intangible Assets | $34,366,000 | $35,809,000 | $38,008,000 | $41,360,000 |
| Current Assets | $1,029,229,000 | $593,828,000 | $333,962,000 | $690,912,000 |
| Other Current Assets | $63,350,000 | $49,979,000 | $52,293,000 | $43,176,000 |
| Receivables | $296,443,000 | $298,400,000 | $253,404,000 | $186,432,000 |
| Receivables Adjustments Allowances | $0 | $-7,000 | $-170,000 | $-171,000 |
| Other Receivables | $5,347,000 | $22,475,000 | $40,405,000 | $36,107,000 |
| Accounts Receivable | $291,096,000 | $275,932,000 | $213,169,000 | $150,496,000 |
| Cash Cash Equivalents And Short Term Investments | $669,436,000 | $245,449,000 | $28,265,000 | $461,304,000 |
| Cash And Cash Equivalents | $669,436,000 | $245,449,000 | $28,265,000 | $461,304,000 |
| Prepaid Assets | - | - | - | $43,176,000 |
Debt
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Total Debt | $126,234,000 | $142,122,000 | $188,867,000 | $130,965,000 |
| Long Term Debt And Capital Lease Obligation | $126,234,000 | $142,122,000 | $138,867,000 | $130,965,000 |
| Net Debt | - | - | $21,735,000 | - |
| Current Debt And Capital Lease Obligation | - | - | $50,000,000 | - |
| Current Debt | - | - | $50,000,000 | - |
Liabilities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Total Liabilities Net Minority Interest | $1,275,321,000 | $1,097,878,000 | $966,108,000 | $707,007,000 |
| Total Non Current Liabilities Net Minority Interest | $170,768,000 | $172,747,000 | $162,638,000 | $149,790,000 |
| Other Non Current Liabilities | $42,734,000 | $28,221,000 | $22,701,000 | $17,745,000 |
| Non Current Deferred Liabilities | $1,800,000 | $2,404,000 | $1,070,000 | $1,080,000 |
| Non Current Deferred Taxes Liabilities | $1,800,000 | $2,404,000 | $1,070,000 | $1,080,000 |
| Current Liabilities | $1,104,553,000 | $925,131,000 | $803,470,000 | $557,217,000 |
| Other Current Liabilities | $53,633,000 | $40,441,000 | $47,547,000 | $27,612,000 |
| Current Deferred Liabilities | $710,585,000 | $559,860,000 | $462,729,000 | $344,641,000 |
| Payables And Accrued Expenses | $255,406,000 | $249,008,000 | $171,997,000 | $127,118,000 |
| Payables | $32,528,000 | $31,869,000 | $33,069,000 | $25,678,000 |
| Accounts Payable | $32,528,000 | $31,869,000 | $33,069,000 | $25,678,000 |
Equity
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Common Stock Equity | $825,545,000 | $558,950,000 | $386,387,000 | $952,928,000 |
| Total Equity Gross Minority Interest | $825,545,000 | $558,950,000 | $386,387,000 | $952,928,000 |
| Stockholders Equity | $825,545,000 | $558,950,000 | $386,387,000 | $952,928,000 |
| Gains Losses Not Affecting Retained Earnings | $-14,743,000 | $-10,072,000 | $-12,392,000 | $-4,846,000 |
| Other Equity Adjustments | $-14,743,000 | $-10,072,000 | $-12,392,000 | $-4,846,000 |
| Retained Earnings | $8,167,000 | $-221,645,000 | $-359,827,000 | $234,984,000 |
Other
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Treasury Shares Number | $70,073 | $70,573 | $71,573 | $180,000 |
| Ordinary Shares Number | $30,630,799 | $30,752,292 | $31,091,694 | $36,006,778 |
| Share Issued | $30,700,872 | $30,822,865 | $31,163,267 | $36,186,778 |
| Tangible Book Value | $128,783,000 | $-139,255,000 | $-314,017,000 | $249,172,000 |
| Invested Capital | $825,545,000 | $558,950,000 | $436,387,000 | $952,928,000 |
| Working Capital | $-75,324,000 | $-331,303,000 | $-469,508,000 | $133,695,000 |
| Capital Lease Obligations | $126,234,000 | $142,122,000 | $138,867,000 | $130,965,000 |
| Total Capitalization | $825,545,000 | $558,950,000 | $386,387,000 | $952,928,000 |
| Treasury Stock | $12,235,000 | $12,322,000 | $12,497,000 | $5,427,000 |
| Additional Paid In Capital | $844,050,000 | $802,681,000 | $770,794,000 | $727,857,000 |
| Capital Stock | $306,000 | $308,000 | $309,000 | $360,000 |
| Common Stock | $306,000 | $308,000 | $309,000 | $360,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $126,234,000 | $142,122,000 | $138,867,000 | $130,965,000 |
| Current Deferred Revenue | $710,585,000 | $559,860,000 | $462,729,000 | $344,641,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $84,929,000 | $75,822,000 | $71,197,000 | $57,846,000 |
| Current Accrued Expenses | $222,878,000 | $217,139,000 | $138,928,000 | $101,440,000 |
| Goodwill | $662,396,000 | $662,396,000 | $662,396,000 | $662,396,000 |
| Net PPE | $252,264,000 | $265,390,000 | $248,917,000 | $222,711,000 |
| Accumulated Depreciation | $-98,869,000 | $-79,404,000 | $-62,116,000 | $-51,101,000 |
| Gross PPE | $351,133,000 | $344,794,000 | $311,033,000 | $273,812,000 |
| Construction In Progress | $21,167,000 | $7,182,000 | $10,518,000 | $10,459,000 |
| Other Properties | $174,292,000 | $184,728,000 | $170,919,000 | $157,534,000 |
| Machinery Furniture Equipment | $134,827,000 | $131,632,000 | $113,592,000 | $89,603,000 |
| Buildings And Improvements | $15,815,000 | $16,419,000 | $13,594,000 | $13,770,000 |
| Land And Improvements | $5,032,000 | $4,833,000 | $2,410,000 | $2,446,000 |
| Properties | $0 | $0 | $0 | $0 |
| Line Of Credit | - | $0 | $50,000,000 | $0 |
Cash Flow Statement (Annual)
Free Cash Flow
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | $572,267,000 | $396,726,000 | $351,171,000 | $235,056,000 |
Operating Activities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Operating Cash Flow | $608,815,000 | $433,374,000 | $388,050,000 | $263,327,000 |
| Cash Flow From Continuing Operating Activities | $608,815,000 | $433,374,000 | $388,050,000 | $263,327,000 |
Investing Activities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Capital Expenditure | $-36,548,000 | $-36,648,000 | $-36,879,000 | $-28,271,000 |
| Investing Cash Flow | $-28,308,000 | $-34,629,000 | $-38,742,000 | $-31,364,000 |
| Cash Flow From Continuing Investing Activities | $-28,308,000 | $-34,629,000 | $-38,742,000 | $-31,364,000 |
| Net Other Investing Changes | $8,240,000 | $2,019,000 | $-1,863,000 | $-3,093,000 |
| Capital Expenditure Reported | - | - | - | $-28,271,000 |
Financing Activities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Repurchase Of Capital Stock | $-169,867,000 | $-144,020,000 | $-847,849,000 | $-62,096,000 |
| Financing Cash Flow | $-154,009,000 | $-182,642,000 | $-775,775,000 | $-44,453,000 |
| Cash Flow From Continuing Financing Activities | $-154,009,000 | $-182,642,000 | $-775,775,000 | $-44,453,000 |
| Net Common Stock Issuance | $-169,867,000 | $-144,020,000 | $-847,849,000 | $-62,096,000 |
Other
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Repayment Of Debt | $0 | $-155,000,000 | $-274,200,000 | $0 |
| Issuance Of Debt | $0 | $105,000,000 | $324,200,000 | $0 |
| Interest Paid Supplemental Data | $171,000 | $3,056,000 | $2,935,000 | $123,000 |
| Income Tax Paid Supplemental Data | $83,567,000 | $76,353,000 | $50,164,000 | $56,243,000 |
| End Cash Position | $669,436,000 | $245,449,000 | $28,265,000 | $461,304,000 |
| Beginning Cash Position | $245,449,000 | $28,265,000 | $461,304,000 | $277,766,000 |
| Effect Of Exchange Rate Changes | $-2,511,000 | $1,081,000 | $-6,572,000 | $-3,972,000 |
| Changes In Cash | $426,498,000 | $216,103,000 | $-426,467,000 | $187,510,000 |
| Proceeds From Stock Option Exercised | $15,858,000 | $11,378,000 | $22,074,000 | $17,643,000 |
| Common Stock Payments | $-169,867,000 | $-144,020,000 | $-847,849,000 | $-62,096,000 |
| Net Issuance Payments Of Debt | $0 | $-50,000,000 | $50,000,000 | $0 |
| Net Short Term Debt Issuance | $0 | $-50,000,000 | $50,000,000 | $0 |
| Short Term Debt Payments | $0 | $-155,000,000 | $-274,200,000 | $0 |
| Short Term Debt Issuance | $0 | $105,000,000 | $324,200,000 | $0 |
| Net PPE Purchase And Sale | $-36,548,000 | $-36,648,000 | $-36,879,000 | $-28,271,000 |
| Purchase Of PPE | $-36,548,000 | $-36,648,000 | $-36,879,000 | $-28,271,000 |
| Change In Working Capital | $157,181,000 | $106,486,000 | $106,055,000 | $66,707,000 |
| Change In Other Working Capital | $174,519,000 | $87,524,000 | $140,142,000 | $88,433,000 |
| Change In Other Current Liabilities | $-21,407,000 | $-18,873,000 | $-15,899,000 | $-15,632,000 |
| Change In Payables And Accrued Expense | $13,917,000 | $83,131,000 | $58,907,000 | $28,022,000 |
| Change In Accrued Expense | $16,882,000 | $82,080,000 | $52,476,000 | $26,156,000 |
| Change In Payable | $-2,965,000 | $1,051,000 | $6,431,000 | $1,866,000 |
| Change In Account Payable | $-2,965,000 | $1,051,000 | $6,431,000 | $1,866,000 |
| Change In Prepaid Assets | $-12,090,000 | $2,986,000 | $-10,175,000 | $-9,134,000 |
| Change In Receivables | $2,242,000 | $-48,282,000 | $-66,920,000 | $-24,982,000 |
| Other Non Cash Items | $19,115,000 | $22,351,000 | $15,888,000 | $16,296,000 |
| Stock Based Compensation | $25,514,000 | $20,516,000 | $21,412,000 | $14,469,000 |
| Deferred Tax | $-26,632,000 | $-25,117,000 | $-23,014,000 | $-37,112,000 |
| Deferred Income Tax | $-26,632,000 | $-25,117,000 | $-23,014,000 | $-37,112,000 |
| Depreciation Amortization Depletion | $29,251,000 | $26,328,000 | $22,341,000 | $21,119,000 |
| Depreciation And Amortization | $29,251,000 | $26,328,000 | $22,341,000 | $21,119,000 |
| Amortization Cash Flow | $1,443,000 | $2,199,000 | $3,352,000 | $5,114,000 |
| Amortization Of Intangibles | $1,443,000 | $2,199,000 | $3,352,000 | $5,114,000 |
| Depreciation | $27,808,000 | $24,129,000 | $18,989,000 | $16,005,000 |
| Net Income From Continuing Operations | $404,386,000 | $282,810,000 | $245,368,000 | $181,848,000 |
| Net Long Term Debt Issuance | - | - | - | $0 |
| Long Term Debt Payments | - | - | - | $0 |